|
Drontal Puppy
|
-
|
V/MRP/08/1590
|
Vetoquinol S.A., Francija
|
QP52AC55
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Febantel,Pyrantel embonate
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Vetoquinol Biowet Sp. z. o. o., Polija;KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
30-May-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 31012024LI (31-Jan-2024)
|
| Labelling text: |
[DOCX] 23102020M (23-Oct-2020)
|
| Summary of product characteristics: |
[DOCX] 23102020ZA (23-Oct-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/08/1590-01 |
|
1 |
Flakons, 50 ml |
-
|
| V/MRP/08/1590-02 |
|
1 |
Flakons, 100 ml |
-
|
|
|
Drontal Dog Flavour
|
-
|
V/DCP/14/0056
|
Vetoquinol S.A., Francija
|
QP52AA51
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0056-01 |
|
2 |
PVH/Al blisteris (necaurspīdīgs), 1 tablete |
-
|
| V/DCP/14/0056-02 |
|
4 |
PVH/Al blisteris (necaurspīdīgs), 1 tablete |
-
|
| V/DCP/14/0056-03 |
|
6 |
PVH/Al blisteris (necaurspīdīgs), 1 tablete |
-
|
| V/DCP/14/0056-04 |
|
24 |
PVH/Al blisteris (necaurspīdīgs), 1 tablete |
-
|
| V/DCP/14/0056-05 |
|
102 |
PVH/Al blisteris (necaurspīdīgs), 1 tablete |
-
|
| V/DCP/14/0056-06 |
|
312 |
PVH/Al blisteris (necaurspīdīgs), 1 tablete |
-
|
|
|
Drontal Dog Flavour XL
|
-
|
V/DCP/17/0043
|
Vetoquinol S.A., Francija
|
QP52AA51
|
dogs
|
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0043-01 |
|
2 |
PP/Al blisteris, 1 tablete |
-
|
| V/DCP/17/0043-02 |
|
4 |
PP/Al blisteris, 1 tablete |
-
|
| V/DCP/17/0043-03 |
|
8 |
PP/Al blisteris, 1 tablete |
-
|
| V/DCP/17/0043-04 |
|
24 |
PP/Al blisteris, 1 tablete |
-
|
| V/DCP/17/0043-05 |
|
48 |
PP/Al blisteris, 1 tablete |
-
|
|
|
Drontal
|
230.20 mg/mg
|
V/NRP/99/0981
|
Vetoquinol S.A., Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Praziquantel, Pyrantel embonate
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
KVP Pharma und Veterinär - Produkte GmbH, Vācija;Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
30-Apr-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 31012025LI (31-Jan-2025)
|
| Labelling text: |
[DOCX] 23102020M (23-Oct-2020)
|
| Summary of product characteristics: |
[DOCX] 31012025ZA (31-Jan-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/99/0981-02 |
|
24 |
Blisteris, 1 tablete |
-
|
| V/NRP/99/0981-04 |
|
2 |
Blisteris, 1 tablete |
-
|
|
|
Drontal Plus Flavour
|
-
|
V/I/21/0045
|
Bayer Animal Health GmbH, Vācija
|
QP52AA51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Febantel, Pyrantel, Praziquantel
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
KVP Pharma und Veterinär - Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
09-Aug-2021
|
| Marketing authorisation valid until: |
08-Aug-2026
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 082021LI (09-Aug-2021)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/21/0045-01 |
|
2 |
PP/PP blisteris, 1 tablete |
-
|
|
|
Drontal
|
230.20 mg
|
V/I/21/0022
|
Vetoquinol S.A., Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Pyrantel embonate, Praziquantel
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija;Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
29-Mar-2021
|
| Marketing authorisation valid until: |
28-Mar-2026
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOC] 25032025LI (25-Mar-2025)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/21/0022-01 |
|
2 |
Blisteris, 1 tablete |
[PDF]
|
|
|
DRONTAL JUNIOR
|
-
|
V/I/21/0060
|
Vetoquinol S.A., Francija
|
QP52AC55
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Pyrantel embonate, Febantel
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
13-Oct-2021
|
| Marketing authorisation valid until: |
12-Oct-2026
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOC] 22042024LI (22-Apr-2024)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/21/0060-01 |
|
1 |
Polipropilēna šļirce, 50 ml |
-
|
|